Products
The IDK® anti-SARS-CoV-2 IgG ELISA (Quantitative) is for the quantitative measurement of IgG antibodies against the novel coronavirus SARS-CoV-2 in human serum or EDTA plasma.
IDK® anti-SARS-CoV-2 IgG ELISA (Quantitative)
$475.00
In Stock
Sample Type (Matrix): EDTA Plasma, Serum
Sample Volume: 10 µl
Species: Human
Incubation time: 2h 15m
Standard Range: 1.25-20 ng/ml
Size: 96 wells
Regulatory Status: For Research Use Only in North America.
Kit Manual: Download
The IDK® anti-SARS-CoV-2 IgG ELISA (Quantitative) is an enzyme-linked immunosorbent assay (ELISA) for the quantitative measurement of IgG antibodies (including neutralizing antibodies) against the novel coronavirus SARS-CoV-2 (COVID-19) in human serum or EDTA plasma.
The assay is an in vitro diagnostic medical device and is intended to be used by professional users in a laboratory environment. This ELISA can be performed manually or using an automated platform. This test serves as a complement to infection diagnosis and is used for the detection of IgG antibodies after a previous infection with SARS-CoV-2 or after COVID-19 vaccination.
The IDK® anti-SARS-CoV-2 IgG ELISA (Quantitative) is for Research Use Only in North America. This is the RUO version of Immundiagnostik part number K 5004.
Additional information
| Weight | 35.5 oz |
|---|---|
| Dimensions | 6.5 × 10 × 4.5 in |